Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Drugmakers are racing to develop the next wave of obesity and diabetes medications that they hope will be even more powerful ...

The shipments have propelled Ireland, a country of only 5.4 million people, to the second-largest goods-trade imbalance with ...

A small, early-stage study published in the journal Headache suggested a diabetes drug may ease migraines by lowering ...

Novo Nordisk on Friday said full results from early-stage trials show that its experimental drug, amycretin, helped ...

Roughly 8 million American teens are living with obesity - that's one in five. For many, their weight has become a painful ...

With semaglutide and tirzepatide dosed once weekly, their estimated average yearly costs in the U.S. are $14,080 and $8,126, ...

Novo Nordisk A/S’s latest experimental obesity drug helped patients lose as much as 24.3% of their weight in a small study, ...

Dr. Tara Narula takes a look at weight-loss medications and how entire families can benefit when one person starts taking the drugs.

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Patients with obesity can now get Zepbound’s strongest doses for a flat rate through Lilly’s self-pay pharmacy.